A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Study Purpose:
The primary objective of this study is to demonstrate a pharmacodynamic effect of CK 2017357 on measures of skeletal muscle function or fatigability in patients with ALS.Disease:
Amyotrophic Lateral Sclerosis (ALS), Familial ALS, Sporadic ALSStudy Type:
Interventional TrialStudy Category:
Drug TrialStudy Status:
Not enrollingPhase:
Phase IIStudy Chair(s)/Principal Investigator(s):
Jeremy M Shefner, MD, PhD (State University of New York - Upstate Medical University)Clinicaltrials.gov ID (11 digit #):
NCT01089010Neals Affiliated?
YesCoordinating Center Contact Information
State University of New York - Upstate Medical University.(JavaScript must be enabled to view this email address)
.(JavaScript must be enabled to view this email address) Syracuse, New York 13210 United States